Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS: FRTX · Delayed Price · USD
0.910
0.00 (0.00%)
Apr 30, 2024, 9:30 AM EDT - Market closed
Fresh Tracks Therapeutics Revenue
In the year 2023, Fresh Tracks Therapeutics had annual revenue of $8.01M with 15.31% growth.
Revenue (ttm)
$8.01M
Revenue Growth
+15.31%
P/S Ratio
0.68
Revenue / Employee
$2,001,500
Employees
4
Market Cap
5.44M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.01M | 1.06M | 15.31% |
Dec 31, 2022 | 6.94M | 6.54M | 1,618.56% |
Dec 31, 2021 | 404.00K | -1.42M | -77.83% |
Dec 31, 2020 | 1.82M | -6.10M | -76.99% |
Dec 31, 2019 | 7.92M | 6.30M | 388.10% |
Dec 31, 2018 | 1.62M | -12.20M | -88.26% |
Dec 31, 2017 | 13.82M | -712.00K | -4.90% |
Dec 31, 2016 | 14.53M | -6.42M | -30.64% |
Dec 31, 2015 | 20.95M | 5.73M | 37.67% |
Dec 31, 2014 | 15.22M | 7.50M | 97.16% |
Dec 31, 2013 | 7.72M | -9.80M | -55.94% |
Dec 31, 2012 | 17.52M | -12.50M | -41.64% |
Dec 31, 2011 | 30.02M | 21.31M | 244.60% |
Dec 31, 2010 | 8.71M | -3.98M | -31.33% |
Dec 31, 2009 | 12.69M | 4.73M | 59.45% |
Dec 31, 2008 | 7.96M | 2.44M | 44.34% |
Dec 31, 2007 | 5.51M | -9.23M | -62.61% |
Dec 31, 2006 | 14.74M | 2.74M | 22.80% |
Dec 31, 2005 | 12.00M | -2.54M | -17.48% |
Dec 31, 2004 | 14.55M | 6.47M | 80.05% |
Dec 31, 2003 | 8.08M | 1.07M | 15.29% |
Dec 31, 2002 | 7.01M | -4.36M | -38.35% |
Dec 31, 2001 | 11.37M | 3.75M | 49.16% |
Dec 31, 2000 | 7.62M | -3.08M | -28.78% |
Dec 31, 1999 | 10.70M | 4.80M | 81.36% |
Dec 31, 1998 | 5.90M | -1.90M | -24.36% |
Dec 31, 1997 | 7.80M | 1.10M | 16.42% |
Dec 31, 1996 | 6.70M | 400.00K | 6.35% |
Dec 31, 1995 | 6.30M | 800.00K | 14.55% |
Dec 31, 1994 | 5.50M | -500.00K | -8.33% |
Dec 31, 1993 | 6.00M | 2.40M | 66.67% |
Dec 31, 1992 | 3.60M | 1.20M | 50.00% |
Dec 31, 1991 | 2.40M | 600.00K | 33.33% |
Dec 31, 1990 | 1.80M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
FRTX News
- 2 months ago - Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th - GlobeNewsWire
- 4 months ago - Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th - GlobeNewsWire
- 4 months ago - Fresh Tracks Therapeutics Announces Listing on OTC Pink Market - GlobeNewsWire
- 4 months ago - Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th - GlobeNewsWire
- 4 months ago - Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 5 months ago - Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 5 months ago - Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders - GlobeNewsWire
- 6 months ago - Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire